United Therapeutics Corporation Deferred Tax Assets, Investments
United Therapeutics Corporation (UTHR) had Deferred Tax Assets, Investments of $0 as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInvestments · last filed 2026-02-25
- 2025-12-31: Deferred Tax Assets, Investments $0.00.
- 2024-12-31: Deferred Tax Assets, Investments $9.60M.
- 2023-12-31: Deferred Tax Assets, Investments $15.30M.
- 2022-12-31: Deferred Tax Assets, Investments $25.00M.
| Period end | Deferred Tax Assets, Investments |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 |
| 2024-12-31 | $9.60M 10-K · filed 2026-02-25 |
| 2023-12-31 | $15.30M 10-K · filed 2025-02-26 |
| 2022-12-31 | $25.00M 10-K · filed 2024-02-21 |
| 2021-12-31 | $1.40M 10-K · filed 2023-02-22 |
| 2020-12-31 | $7.40M 10-K · filed 2022-02-24 |
| 2019-12-31 | $19.50M 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |